Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2013 by Iperboreal Pharma Srl
Sponsor:
Information provided by (Responsible Party):
Iperboreal Pharma Srl
ClinicalTrials.gov Identifier:
NCT00755456
First received: September 18, 2008
Last updated: March 25, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)